Announcement of Winners of Doctors 2.0 & You International Digital Health Start-up Contest #doctors20

Doctors 2.0 & YouDoctors 2.0 & You 4th Edition Start-up Contest announced the winning and runner-up digital health start-up companies. First place was awarded to Medivizor (Israel) represented by Tal Givoly. Second place was awarded to Medexo (Germany) represented by Jan-Christoph Loh. The winners of the Start-up Contest were chosen for the quality of the solution they bring to a health problem and their likelihood to succeed. al Givoly, co-founder of Medivizor, winner of the start-up contest will have the opportunity to present his company on stage at the sister conference of Doctors 2.0 & You, Stanford Medicine X, founded by Dr Larry Chu, in September, 2014. Both companies, Medivizor and Medexo will also return to speak at the 5th edition of Doctors 2.0 & You, founded by Denise Silber.

Dr Larry Chu (Medicine X) observed that "This year's start-up competition at Doctors 2.0 & You highlighted leading international innovators in digital health from five countries, a very talented group of start-ups. We are proud to welcome Medivizor to present on the Medicine X main stage at Stanford in the fall of this year." Denise Silber (Doctors 2.0 & You) noted that ” Doctors 2.0 & You is happy to assemble such talented companies and to provide them with increased visibility and exposure to a very motivated and experienced jury."

"Medivizor's mission is to improve the lives of people with serious medical conditions and those who care for them by providing all of the truly relevant and personalized information. The solution, now in public beta, combines patent-pending technology, medical expertise, and the wisdom of the crowd." According to Tal Givoly, CEO of Medivizor, "Doctors 2.0 & You brought together a diverse group of pioneering healthcare professionals, patients, entrepreneurs, and policy makers, and everything in between. It was invigorating to have met so many amazing individuals - each with sincere eagerness to make the world better. It was particularly gratifying that the judges and the participants recognized Medivizor as the company most likely to succeed in the startup contest among the many companies and entrepreneurs that applied and the terrific short list of 7 companies that presented."

"Medexo offers patients the possibility to obtain a medical second opinion from independent leading experts via the internet. Through this assessment, the patient gains additional information and security for his or her decision." For Jan-Christoph Loh, CEO of Medexo, "I am really happy to have achieved this result in the Doctors 2.0 & You start-up challenge and to get the opportunity to return to speak at Doctors 2.0 & You next year. On behalf of our whole team, I thank Denise and the Doctors2.0 & You team for two great days of interesting speeches and a lot of networking. It was an honour to be part of this great conference and I congratulate Tal of Medivizor for his awesome pitch performance and their motivating solution! The whole team of Medexo and I are looking forward to be a part of Doctors2.0 & You again next year."

The Start-up Contest included 7 start-up finalists. Esperity (Be), InsightMedi (Sp), Kosmo (Fr), Medexo (De), MIS (Fr), Medivizor (Il), Umanlife (Fr). For more information about the start-ups, see this link. The session was chaired by Dr Larry Chu, Executive Director of Stanford Medicine X. The diversified start-up contest jury was composed of Eugene Borukhovich, Softserve (Netherlands), Dr Marc Braman, Lifestyle Medicine Foundation (USA), Yann Bry, Axa (France), Stanley Li, DXY (China), Izabella Mesko-Vajda, Peto Institute (Hungary), Sandra van Rijswijk, Games for Health Europe (Netherlands).

About Doctors 2.0 & You
The Doctors 2.0 & You conference series, founded by Denise Silber is organized by Basil Strategies, digital health consultancy (Paris). It is the only international congress devoted to the understanding of how physicians use New Technologies, Web 2.0 tools and Social Media to communicate with colleagues, patients, payers, pharmaceutical companies and public agencies. The 4th edition took place in Paris on June 5-6, 2014. The conference website and blog includes videos, past presentations, interviews. Doctors 2.0 & You also organizes customized events and trainings.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...